Creating application specific custom antibodies in 60 days!
![v870-tang-04 [Converted]](https://precisionantibody.com/wp-content/uploads/elementor/thumbs/v870-tang-04-Converted-qswekwhgmgciyp6ac0hllkjbqr3975a6d6l4zr11hs.png "v870-tang-04 [Converted]")
Whether you are looking into custom monoclonal or polyclonal antibody development, the first and foremost important step is to understand your goals, your unmet needs, & your intended utility.
Selecting the appropriate antigen format ensures successful immunization & development of application specific antibodies. Our proprietary immunization strategy achieves rapid hyper-maturation & drives strong titer development, for optimal results in the subsequent antibody development.
Using "Smart Fusion" technology followed by single cell cloning, we generate highcontent hybridomas that produce antibodies targeting a wide range of epitopes with ideal binding affinities. We employ precise screening methods to ensure compatibility with your specific application.
Selecting antibodies based on specific binding parameters is an integral part of our process. By eliminating antibodies with matrix effects and employing epitope binning and scouting assays, we ensure the selection of antibodies with optimal binding properties.
Upon project completion, we deliver customer-selected clones and offer antibody production and purification (mg - grams). We also provide master and working cell bank generation and storage, antibody stability assays, and determine variable region sequences of antibodies from human and other animal
species.
Whether you are looking into custom monoclonal or polyclonal antibody development, the first and foremost important step is to understand your goals, your unmet needs, & your intended utility.
Selecting the appropriate antigen format ensures successful immunization & development of application specific antibodies. Our proprietary immunization strategy achieves rapid hyper-maturation & drives strong titer development, for optimal results in the subsequent antibody development.
Using "Smart Fusion" technology followed by single cell cloning, we generate highcontent hybridomas that produce antibodies targeting a wide range of epitopes with ideal binding affinities. We employ precise screening methods to ensure compatibility with your specific application.
Selecting antibodies based on specific binding parameters is an integral part of our process. By eliminating antibodies with matrix effects and employing epitope binning and scouting assays, we ensure the selection of antibodies with optimal binding properties.
Upon project completion, we deliver customer-selected clones and offer antibody production and purification (mg - grams). We also provide master and working cell bank generation and storage, antibody stability assays, and determine variable region sequences of antibodies from human and other animal
species.
Whether you are looking into custom monoclonal or polyclonal antibody development, the first and foremost important step is to understand your goals, your unmet needs, & your intended utility.
Using "Smart Fusion" technology followed by single cell cloning, we generate highcontent hybridomas that produce antibodies targeting a wide range of epitopes with ideal binding affinities. We employ precise screening methods to ensure compatibility with your specific application.
Upon project completion, we deliver customer-selected clones and offer antibody production and purification (mg - grams). We also provide master and working cell bank generation and storage, antibody stability assays, and determine variable region sequences of antibodies from human and other animal
species.
Selecting the appropriate antigen format ensures successful immunization & development of application specific antibodies. Our proprietary immunization strategy achieves rapid hyper-maturation & drives strong titer development, for optimal results in the subsequent antibody development.
Selecting antibodies based on specific binding parameters is an integral part of our process. By eliminating antibodies with matrix effects and employing epitope binning and scouting assays, we ensure the selection of antibodies with optimal binding properties.
Precision Antibody™ has consistently delivered high-quality antibodies for diverse & unique applications. Our success rate in providing antibodies that perform as intended exceeds 95%. Partner with us for your next successful custom antibody project.
Time is money, and we deliver. Precision Antibody™ can provide antibodies for your specific application in ~ 60 days. Reach out for your next antibody development needs and experience fast, reliable results.
Experience the effectiveness of Precision Antibody™’s personalized support throughout your custom antibody development journey. From initial consultation to final delivery, we provide expert guidance and troubleshooting for antibody development that meets your unique requirements.
No two projects are the same, and neither are our solutions. We deliver antibody development services tailored to your specific requirements. Partner with us today for custom solutions designed to fit your project.
Novel mono- & polyclonal antibody development in just 30-60 days! Precision Antibody™ develops Mouse & Rat monoclonal antibodies, Fully Human monoclonal antibodies, Humanized monoclonal antibodies, Rat, Rabbit, & Goat polyclonal antibodies. Precision Antibody™ customizes project strategies to ensure the delivery of antibodies that work in the intended applications.
From milligram to gram-scale production, Precision Antibody™ offers antibody production and purification from hybridomas, stable cell lines, or transiently transfected cells in serum-free media, as well as from ascites. Monoclonal and polyclonal antibodies are affinity-purified, buffer exchanged, concentration adjusted, and delivered in vials to meet your specifications with a Certificate of Analysis.
During an antibody development campaign, the determination of Antibody biochemical and biophysical characteristics is a necessary step for selecting the best antibodies for an intended application. The determination of antibody binding characteristics by Octet or Biacore is an integral part of our antibody development process.
Precision Antibody™ offers services including:
Antibodies play a crucial role across diagnostic, biomarker, and therapeutic fields, with each application requiring precise development, verification, and validation. Precision Antibody offers specialized in vivo and in vitro assays to evaluate performance characteristics of selected antibodies. Service includes:
Your research deserves the best. Explore our catalog today to find the antibodies you need for your research. Take your project to the next level with our premium antibodies and dedicated customer support.
Precision Antibody™ is always here to help you with your antibody needs.
For over 20 years, Precision Antibody™ has been a trusted partner, delivering highquality, epitope-rich, rapid antibody development services to pharmaceutical, biotech, academic, and federal laboratory clients. While many companies offer similar services at varying costs, developing antibodies that truly perform in your specific application demands a higher level of expertise.
Our success rate in delivering antibodies that function as intended is over 95%, compared to the industry average of less than 50%. In just about 20 days, we generate hyper-immune (IgG) serum titers (>1:100,000), suitable for hybridoma development. Additionally, we produce high-affinity, epitope-rich antibodies within approximately 60 days, tailored to your target.
Each antibody development project is unique, and our deep understanding of the biology behind your project sets us apart. Precision Antibody™ team of scientists, with extensive expertise in immunology, cancer research, cell biology, molecular biology, and biochemistry, ensures that we approach each project with achieving the goal in mind.
We begin with an in-depth discussion, paying close attention to your specific project and intended applications of the antibodies. Antigen design and screening strategies will be tailored to those needs and will be presented to you. You will receive a detailed quote outlining the scope of work.
At Precision Antibody™, we continuously enhance our proprietary technology to offer cost-effective, high-quality antibody development. Your work remains confidential, and all products we generate are yours.
We are AAALAC and OLAW accredited. We ensure that our work is performed with the highest quality and care.
Our milestone-driven, phase-based pricing model ensures transparency and flexibility as your project progresses. At each phase, we provide comprehensive data, enabling you to make informed decisions about moving forward while minimizing risk.
Clear and consistent communication throughout the project is key to
ensuring its successful
completion.
All projects are handled confidentially. We are happy to have a CDA & MSA in place. All the clones developed are yours. Precision Antibody™ does not retain any ownership.
We are the preferred and longterm service provider for leading global pharmaceutical and biotechnology companies worldwide. We also work with government institutions under a Blanket Purchase Agreements (BPA) and contracts. Our reputation as a trusted antibody developer is backed by a proven track
record of delivering comprehensive, high-quality
services, making us the topchoice for
custom antibody development projects.
With a typical timeframe of 30 to 60 days, we are committed to developing antibodies that precisely meet your application needs. Our success rate in delivering clones that perform in client-specific applications exceeds 95%.
Our Precision Antibody™ team has developed custom antibodies used for many applications such as: Receptor agonistic antibodies, Antibodies for sandwich ELISA, Conformation-specific antibodies, Antibodies against small molecule drugs, carbohydrates, lipids, and nucleic acids, etc.
Our deliverables include, but are not limited to, polyclonal antibodies, hybridoma culture supernatants, purified antibodies, and customer-selected hybridoma clones along with appropriate results and reports.
We offer a range of antibody development programs tailored to your needs and budget. Our customantibody development projects are milestone-based, and you are paying for the completed milestones as the project progresses. For more information, please contact us.
We are AAALAC and OLAW accredited. We ensure that our work is performed with the highest quality and care.
Our milestone-driven, phase-based pricing model ensures transparency and flexibility as your project progresses. At each phase, we provide comprehensive data, enabling you to make informed decisions about moving forward while minimizing risk.
Clear and consistent communication throughout the project is key to
ensuring its successful
completion.
All projects are handled confidentially. We are happy to have a CDA & MSA in place. All the clones developed are yours. Precision Antibody™ does not retain any ownership.
We are the preferred and longterm service provider for leading global pharmaceutical and biotechnology companies worldwide. We also work with government institutions under a Blanket Purchase Agreements (BPA) and contracts. Our reputation as a trusted antibody developer is backed by a proven track record of delivering comprehensive, high-quality services, making us the topchoice for custom antibody development projects.
With a typical timeframe of 30 to 60 days, we are committed to developing antibodies that precisely meet your application needs. Our success rate in delivering clones that perform in client-specific applications exceeds 95%.
Our Precision Antibody™™ team has developed custom antibodies used for many applications such as: Receptor agonistic antibodies, Antibodies for sandwich ELISA, Conformation-specific antibodies, Antibodies against small molecule drugs, carbohydrates, lipids, and nucleic acids, etc.
We are AAALAC and OLAW accredited. We ensure that our work is performed with the highest quality and care.
Our milestone-driven, phase-based pricing model ensures transparency and flexibility as your project progresses. At each phase, we provide comprehensive data, enabling you to make informed decisions about moving forward while minimizing risk. Clear and consistent communication throughout the project is key to ensuring its successful
completion.
All projects are handled confidentially. We are happy to have a CDA & MSA in place. All the clones developed are yours. Precision Antibody™ does not retain any ownership.
We are the preferred and longterm service provider for leading global pharmaceutical and biotechnology companies worldwide. We also work with government institutions under a Blanket Purchase Agreements (BPA) and contracts. Our reputation as a trusted antibody developer is backed by a proven track record of delivering comprehensive, high-quality services, making us the topchoice for custom antibody development projects.
With a typical timeframe of 30 to 60 days, we are committed to developing antibodies that precisely meet your application needs. Our success rate in delivering clones that perform in client-specific applications exceeds 95%.
Our Precision Antibody™™ team has developed custom antibodies used for many applications such as: Receptor agonistic antibodies, Antibodies for sandwich ELISA, Conformation-specific antibodies, Antibodies against small molecule drugs, carbohydrates, lipids, and nucleic acids, etc.
Our deliverables include, but are not limited to, polyclonal antibodies, hybridoma culture supernatants, purified antibodies, and customer-selected hybridoma clones along with appropriate results and reports.
We offer a range of antibody development programs tailored to your needs and budget. Our customantibody development projects are milestone-based, and you are paying for the completed milestones as the project progresses. For more information, please contact us.
We are AAALAC and OLAW accredited. We ensure that our work is performed with the highest quality and care.
Our milestone-driven, phase-based pricing model ensures transparency and flexibility as your project progresses. At each phase, we provide comprehensive data, enabling you to make informed decisions about moving forward while minimizing risk. Clear and consistent communication throughout the project is key to ensuring its successful completion.
All projects are handled confidentially. We are happy to have a CDA & MSA in place. All the clones developed are yours. Precision Antibody™ does not retain any ownership.
Our Precision Antibody™ team has developed custom antibodies used for many applications such as: Receptor agonistic antibodies, Antibodies for sandwich ELISA, Conformation-specific antibodies, Antibodies against small molecule drugs, carbohydrates, lipids, and nucleic acids, etc.
Our deliverables include, but are not limited to, polyclonal antibodies, hybridoma culture supernatants, purified antibodies, and customer-selected hybridoma clones along with appropriate results and reports.
We offer a range of antibody development programs tailored to your needs and budget. Our customantibody development projects are milestone-based, and you are paying for the completed milestones as the project progresses. For more information, please contact us.
We are the preferred and longterm service provider for leading global pharmaceutical and biotechnology companies worldwide. We also work with government institutions under a Blanket Purchase Agreements (BPA) and contracts. Our reputation as a trusted antibody developer is backed by a proven track
record of delivering comprehensive, high-quality
services, making us the topchoice for
custom antibody development projects.
With a typical timeframe of 30 to 60 days, we are committed to developing antibodies that precisely meet your application needs. Our success rate in delivering clones that perform in client-specific applications exceeds 95%.
Celebrating over 20 years in business, Precision Antibody™ has found itself in the forefront of the global Custom Antibody industry. Led by the innovative minds in immunology and antibody development field, Precision Antibody™ not only has implemented a cutting-edge technique in antigen design, antibody development, production, and other analyses, but is also constantly working on ways to improve and advance technology to match the ever-changing world of science.
Antibody Development Experience
Successful Projects Delivered
Contracted Organizations
Precision Antibody™ offers fully human antibody development using transgenic mice. We are capable of developing a large number of antigen-specific clones producing fully human IgG in about 60 days. Precision Antibody™ uses their proprietary procedures and platform to rapidly generate application specific monoclonal antibodies (mAbs). Please inquire.
Precision Antibody™ has become a household name for customized mAb development. Our team of scientists will develop a strategy to match the needs of your diagnostic or therapeutic program, including modifying the scale and scope of the program to identify mAbs for drug development.
Precision Antibody™ has extensive experience developing anti-idiotypic antibodies (anti-idiotype) for pharmacokinetic (PK) and pharmacodynamic studies. Our team of immunologists has developed a successful immunization protocol that has vastly improved the generation of anti-idiotypic antibodies. We have developed anti-idiotypes for large and small biotechnology and pharmaceutical customers.
Rapid monoclonal antibody development to generate Monoclonal Antibodies for basic research in immunoassays. Precision Antibody™ can target proteins, peptides, small molecules and other antigens to make mAbs as antibody tools. mAbs are identified for binding utility and can be characterized for Ab production and binding affinity.
Main usage
Qualitative detection
Qualitative detection
Qualitative detection
Host species
Rabbit
Guinea pig
Goat
Mouse
Rat
Mouse
Humanized Mouse
Rat
Patient Derived cells
CHO
HEK293
Antigen type
All
Duration
30–80 Days
60 Days
6 – 8 Weeks or Volume dependent
Specificity
High
High
High
Batch consistency
Medium to High
High
High
Cost
Low
Medium
Medium to High or Dependent upon quantity
Experience a dedicated approach to custom antibodies with unmatched expertise, fast delivery, and personalized service. Let’s collaborate to bring your research to life.
We are excited to announce that Precision Antibody™™ is a silver sponsor of the upcoming ImmunoBioseries 2024 West Coast Edition, happening on February 8-9th in sunny San Diego. This event marks a pivotal gathering for professionals in the immunotherapy and biomarker communities, showcasing the latest advancements and discussions in the
The JP Morgan conference, a notable event in the biotech industry which took place — to — January 2024, has cast a spotlight on antibody-drug conjugates (ADCs), as detailed in a Fierce Biotech article. These innovative therapies combine the targeted approach of monoclonal antibodies with the potency of cytotoxic drugs,
2024’s Breakthrough in Monoclonal Antibody Development: Insights from WuXi-BioNTech’s Landmark Deal The rapid evolution of monoclonal antibody development in 2024 marks a significant era in medical and scientific advancements. This year, we witnessed a landmark deal between WuXi Biologics and BioNTech, as reported by Seeking Alpha, showcasing the dynamic nature
President & Founder
Precision Antibody™’s founder Dr. Jun Hayashi is an accomplished Developmental Immunologist who has established the antibody development platform unique to the company.
CEO
Dr. Ginette Serrero, CEO is a Cancer Biologist with expertise in Biochemistry and target discovery which add basic understanding and solving of biological questions to the antibody development strategy. They have been working together and have had long and successful careers in Academia and Industry.
Precision Antibody™ is the forefront of the global Custom Antibody industry & it is led by the innovative minds in immunology and antibody development field.
